publication date: Sep. 12, 2014

Lasker Foundation Names 2014 Award Winners

announced its 2014 award winners.

• Mary-Claire King, of the University of Washington, received the Lasker-Koshland Special Achievement Award for her contributions to medical science and human rights.

• Kazutoshi Mori, of Kyoto University, and Peter Walter, of the University of California, San Francisco, received the Albert Lasker Basic Medical Research Award for research into a key quality-control system in the cell, the unfolded protein response.

• Alim Louis Benabid, of Joseph Fourier University, and Mahlon DeLong, of Emory University, for clinical research for developing a surgical technique that reduces tremors and restores motor function in patients who have advanced Parkinson’s disease.

“Walter and Mori zeroed in on the molecular machinery that senses excessive unfolded proteins, and they exposed the process by which cells correct that problem; DeLong pinpointed a region of the brain that plays a central role in Parkinson’s disease, and Benabid applied a novel technique to that region and alleviated symptoms; and King discovered that certain women with early-onset breast cancer owe their disease to a harmful version of a particular gene, BRCA1,” Joseph Goldstein, chair of the Lasker Medical Research awards jury, said in a statement.


ANDREAS HOCHHAUS and ROBERT GALE were named co-editors-in-chief of Leukemia.

Hochhaus is interim head of the Department of Hematology and Medical Oncology at University Medical Center Jena. Gale is visiting professor of hematology at the Imperial College London.

They will succeed Nicole Muller-Bérat Killmann, co-founder and editor of Leukemia, who passed away in February. She founded the journal with her husband, Sven-Aage Killmann in 1987, and became editor-in-chief after his death. 

Hillard Lazarus, professor of … Continue reading 40-34 The Cancer Letter In Brief

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.